Amersham Biosciences has released a group of Biotrak ELISA substrates for biomarkers involved in neurodegenerative research. The markers include: beta amyloid 1-20, beta amyloid 1-42, and alpha synuclein. The assays have been validated to measure disease samples including brain tissue, serum, plasma, and cerebrospinal fluid.
Amersham Biosciences, Helix
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.